Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Stock

Equities

300452

CNE100001ZH5

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-14 pm EDT 5-day change 1st Jan Change
12.57 CNY -1.64% Intraday chart for Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. -1.80% -11.73%
Sales 2023 * 830M 115M Sales 2024 * 967M 134M Capitalization 2.92B 403M
Net income 2023 * 154M 21.28M Net income 2024 * 187M 25.84M EV / Sales 2023 * 3.52 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 3.02 x
P/E ratio 2023 *
19.3 x
P/E ratio 2024 *
15.7 x
Employees 905
Yield 2023 *
-
Yield 2024 *
-
Free-Float 57.24%
More Fundamentals * Assessed data
Dynamic Chart
Tranche Update on Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. announces an Equity Buyback for CNY 32 million worth of its shares. CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. authorizes a Buyback Plan. CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Sunhere Pharmaceutical Excipients Selling 320 Million Yuan Convertible Bonds MT
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 17 May 2023 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. announced a financing transaction CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on May 26, 2022 CI
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Approves Dividend for 2021 CI
More news
1 day-1.64%
1 week-1.80%
Current month-0.87%
1 month-2.10%
3 months-8.38%
6 months-18.32%
Current year-11.73%
More quotes
1 week
12.46
Extreme 12.46
13.10
1 month
12.28
Extreme 12.28
13.20
Current year
9.92
Extreme 9.92
14.51
1 year
9.92
Extreme 9.92
19.47
3 years
9.68
Extreme 9.6846
21.53
5 years
8.09
Extreme 8.0947
24.02
10 years
3.54
Extreme 3.5404
28.59
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 01-04-26
Director of Finance/CFO 52 20-03-31
Chairman 38 08-12-31
Members of the board TitleAgeSince
Chief Executive Officer 59 01-04-26
Director/Board Member 64 12-08-01
Director/Board Member 50 05-12-31
More insiders
Date Price Change Volume
24-04-15 12.57 -1.64% 3,158,631
24-04-12 12.78 +0.63% 1,626,800
24-04-11 12.7 -0.24% 1,386,123
24-04-10 12.73 -1.70% 2,450,840
24-04-09 12.95 +1.17% 2,558,603

End-of-day quote Shenzhen S.E., April 14, 2024

More quotes
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. is principally engaged in the research and development, production and distribution of pharmaceutical excipients. Its major products include cellulose microciystalline, esium stearate, carboxymethyl starch sodium, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, film coating powder, carboxymethylcellulose sodium, medicinal dextrin, medicinal starch and silicon dioxide, among others. Its products are mainly used in the production of filler, adhesive, disintegrating agent, lubricating agent and coating materials, among others.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.57 CNY
Average target price
18 CNY
Spread / Average Target
+43.20%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300452 Stock